Skip to content
Open access · CC-BY via OpenAlex

Mesenchymal Stem Cell Exosomes as Immunomodulatory Therapy for Corneal Scarring

Hon Shing Ong, Andri K. Riau, Gary Hin‐Fai Yam, Nur Zahirah Binte M. Yusoff, Evelina Han, Tze-Wei Goh, Ruenn Chai Lai, Sai Kiang Lim, Jodhbir Singh Mehta

International Journal of Molecular Sciences · 2023 · ▲ 51 citations

Abstract

Corneal scarring is a leading cause of worldwide blindness. Human mesenchymal stem cells (MSC) have been reported to promote corneal wound healing through secreted exosomes. This study investigated the wound healing and immunomodulatory effects of MSC-derived exosomes (MSC-exo) in corneal injury through an established rat model of corneal scarring. After induction of corneal scarring by irregular phototherapeutic keratectomy (irrPTK), MSC exosome preparations (MSC-exo) or PBS vehicle as controls were applied to the injured rat corneas for five days. The animals were assessed for corneal clarity using a validated slit-lamp haze grading score. Stromal haze intensity was quantified using in-vivo confocal microscopy imaging. Corneal vascularization, fibrosis, variations in macrophage phenotypes, and inflammatory cytokines were evaluated using immunohistochemistry techniques and enzyme-linked immunosorbent assays (ELISA) of the excised corneas. Compared to the PBS control group, MSC-exo treatment group had faster epithelial wound closure (0.041), lower corneal haze score (p = 0.002), and reduced haze intensity (p = 0.004) throughout the follow-up period. Attenuation of corneal vascularisation based on CD31 and LYVE-1 staining and reduced fibrosis as measured by fibronectin and collagen 3A1 staining was also observed in the MSC-exo group. MSC-exo treated corneas also displayed a regenerative immune phenotype characterized by a higher infiltration of CD163+, CD206+ M2 macrophages over CD80+, CD86+ M1 macrophages (p = 0.023), reduced levels of pro-inflammatory IL-1β, IL-8, and TNF-α, and increased levels of anti-inflammatory IL-10. In conclusion, topical MSC-exo could alleviate corneal insults by promoting wound closure and reducing scar development, possibly through anti-angiogenesis and immunomodulation towards a regenerative and anti-inflammatory phenotype.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/ijms24087456
Canonical
link ↗
Fetched
2026-10-17 MST

Cite this

APA
Ong, H.S., Riau, A.K., Yam, G.H., Yusoff, N.Z.B.M., Han, E., Goh, T., Lai, R.C., Lim, S.K., &amp; Mehta, J.S. (2023). Mesenchymal Stem Cell Exosomes as Immunomodulatory Therapy for Corneal Scarring. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms24087456
Vancouver
Ong HS, Riau AK, Yam GH, Yusoff NZBM, Han E, Goh T, et al. Mesenchymal Stem Cell Exosomes as Immunomodulatory Therapy for Corneal Scarring. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24087456.
BibTeX
@article{hon2023Mesenc, title = {Mesenchymal Stem Cell Exosomes as Immunomodulatory Therapy for Corneal Scarring}, author = {Hon Shing Ong and Andri K. Riau and Gary Hin‐Fai Yam and Nur Zahirah Binte M. Yusoff and Evelina Han and Tze-Wei Goh and Ruenn Chai Lai and Sai Kiang Lim and Jodhbir Singh Mehta}, journal = {International Journal of Molecular Sciences}, year = {2023}, doi = {10.3390/ijms24087456}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings